GGrantIndex
← Leaderboards

Ashok Kumar

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗
$14,145,191
Attributed
$17,982,173
Total exposure
14
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.3M · FY2010–25
$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,501,227 · 15

By mechanism

R01$11,495,012 · 6
TL4$3,841,434 · 1
UL1$2,519,054 · 1
R21$1,495,167 · 4
RL5$583,090 · 1
P30$567,470 · 2

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsVisionPathogenRetinaInfectionInflammatory ResponseMediatingTissuesEndophthalmitisMouse ModelPreventBacterial EndophthalmitisSignal TransductionInflammatoryInflammationPathway InteractionsBlindnessPathogenesisOperative Surgical ProceduresStaphylococcus AureusInsightComplicationEye InfectionsResponse

Grant awards (49)

Defining Ocular Monkey Pox Pathogenic Mechanisms$713,991
R01 · FY2025 · EY
Ferroptosis in bacterial endophthalmitis: Mechanisms and Therapeutic targeting$453,470
R01 · FY2025 · EY · contact PI
Vitreous metabolic perturbations during bacterial and fungal endophthalmitis$388,190
R01 · FY2025 · EY · contact PI
Targeting NAD metabolism to ameliorate bacterial endophthalmitis$325,703
R01 · FY2025 · EY · contact PI
Differential impact of acute and chronic opioids on ocular innate immunity and infections$192,500
R21 · FY2025 · EY · contact PI
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection$520,349
R01 · FY2024 · EY
Vitreous metabolic perturbations during bacterial and fungal endophthalmitis$487,174
R01 · FY2024 · EY · contact PI
Ferroptosis in bacterial endophthalmitis: Mechanisms and Therapeutic targeting$453,470
R01 · FY2024 · EY · contact PI
Targeting NAD metabolism to ameliorate bacterial endophthalmitis$332,016
R01 · FY2024 · EY · contact PI
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection$520,349
R01 · FY2023 · EY
Targeting NAD metabolism to ameliorate bacterial endophthalmitis$350,674
R01 · FY2023 · EY · contact PI
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection$192,500
R21 · FY2023 · AI · contact PI
Immunology (I) Core$108,094
P30 · FY2023 · EY · contact PI
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection$504,736
R01 · FY2022 · EY
Targeting NAD metabolism to ameliorate bacterial endophthalmitis$368,848
R01 · FY2022 · EY · contact PI
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection$231,000
R21 · FY2022 · AI · contact PI
Immunology (I) Core$108,094
P30 · FY2022 · EY · contact PI
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection$534,349
R01 · FY2021 · EY
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis$373,450
R01 · FY2021 · EY · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis$371,991
R01 · FY2021 · EY · contact PI
Immunology (I) Core$108,094
P30 · FY2021 · EY · contact PI
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis$385,000
R01 · FY2020 · EY · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis$383,497
R01 · FY2020 · EY · contact PI
Genomic evidences based novel therapy for Staphylococcal infections$244,054
R21 · FY2020 · AI · contact PI
Immunology (I) Core$108,094
P30 · FY2020 · EY · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis - Diversity Supplement$55,155
R01 · FY2020 · EY · contact PI
Research Enhancement for BUILDing Detroit (ReBUILDetroit)$1,014,177
TL4 · FY2019 · GM
Research Enhancement for BUILDing Detroit (ReBUILDetroit)$688,454
UL1 · FY2019 · GM
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis$385,000
R01 · FY2019 · EY · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis$383,497
R01 · FY2019 · EY · contact PI
Role of ABCG1 in Zika virus induced chorioretinal atrophy$231,000
R21 · FY2019 · AI · contact PI
Genomic evidences based novel therapy for Staphylococcal infections$211,613
R21 · FY2019 · AI · contact PI
Immunology (I) Core$135,094
P30 · FY2019 · EY · contact PI
Research Enhancement for BUILDing Detroit (ReBUILDetroit)$1
RL5 · FY2019 · GM
REBUILD Detroit (Student Training Core)$2,827,257
TL4 · FY2018 · GM
REBUILD Detroit (Student Training Core)$1,830,600
UL1 · FY2018 · GM
REBUILD Detroit$583,089
RL5 · FY2018 · GM
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis$385,000
R01 · FY2018 · EY · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis$383,497
R01 · FY2018 · EY · contact PI
Role of ABCG1 in Zika virus induced chorioretinal atrophy$192,500
R21 · FY2018 · AI · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis$58,000
R01 · FY2018 · EY · contact PI
Role of AMP-activated protein kinase in bacterial endophthalmitis$396,675
R01 · FY2017 · EY · contact PI
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis$385,000
R01 · FY2017 · EY · contact PI
Toll-like receptors and bacterial endophthalmitis$286,003
R01 · FY2014 · EY · contact PI
Toll-like receptors and bacterial endophthalmitis$277,248
R01 · FY2013 · EY · contact PI
Toll-like receptors and bacterial endophthalmitis$291,840
R01 · FY2012 · EY · contact PI
Toll-like receptors and bacterial endophthalmitis$145,000
R01 · FY2012 · EY · contact PI
Toll-like receptors and bacterial endophthalmitis$291,840
R01 · FY2011 · EY · contact PI
Toll-like receptors and bacterial endophthalmitis$304,000
R01 · FY2010 · EY · contact PI